Ethical, Societal, and Policy Issues in Germline Gene Editing

Wednesday, November 6

A variety of stakeholders will present and discuss considerations surrounding germline gene editing, including current legal status for clinical research in the US and throughout the world; recent proposals to limit clinical applications; and potential mechanisms necessary to achieve societal consensus.

Programming schedule is as follows:

  • Current international legal and regulatory landscape for clinical use of germline gene editing
  • Perspectives on parameters for restrictions on germline gene editing
  • Approaches to international engagement, monitoring, and prevention of violations


  • Member: $200
  • Non-Member: $250

Register today for the Wednesday, Novemeber 6 session, Ethical, Societal, and Policy Issues in Germline Gene Editing, or all of the ASGCT 2019 Policy Summit.

ASGCT Policy Summit
November 4 – 6 | Washington D.C.